Papaverine inhibits binding of [3H]-prazosin and [3H]-yohimbine to rat renal cortical membranes.
We examined the effects of papaverine on specific [3H]-prazosin and [3H]-yohimbine bindings to rat renal cortical membranes and compared these effects with those of verapamil. Papaverine inhibited both ligand bindings with KI values of 4.2 +/- 1.7 microM and 48.4 +/- 8.7 microM (N = 5) in the inhibition of [3H]-prazosin and [3H]-yohimbine bindings, respectively. In contrast with verapamil, which competitively inhibited both ligand bindings, papaverine inhibited them in a different manner. Although the affinities of these ligand binding sites for papaverine are low, alpha-receptor blockade is a possible mechanism of action of this compound.